Loading…
Loading…
BSX · NYSE · Healthcare
Estimate fair value using the Graham Number, earnings-based model, and PEG-adjusted valuation. Three independent methods averaged together.
Market Cap
$105.67B
P/E Ratio
36.46
Forward P/E
—
EPS
$1.96
PEG Ratio
1.73
Book Value
$16.37
Dividend Yield
—
Profit Margin
14.44%
ROE
11.96%
Use the interactive fair value with pre-loaded data for Boston Scientific Corp. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for BSX: